Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | HLA-G |
| Upstream (Parents) |
|---|
| (<<) ACTB → HLA-G |
| (<<) ATP2A2 → HLA-G |
| (<<) BCL2L1 → HLA-G |
| (<<) CORO1A → HLA-G |
| (<<) DAZAP2 → HLA-G |
| (<<) HLA-A → HLA-G |
| (<<) JUND → HLA-G |
| (<<) MCL1 → HLA-G |
| (<<) PLD3 → HLA-G |
| (<<) PTK2B → HLA-G |
| (<<) RAC2 → HLA-G |
| (<<) RHOA → HLA-G |
| Downstream (Children) |
|---|
| HLA-G → ANKRD57 (>>) |
| HLA-G → ARSJ (>>) |
| HLA-G → ATP7B (>>) |
| HLA-G → BCAR3 (>>) |
| HLA-G → CD4 (>>) |
| HLA-G → CSTA (>>) |
| HLA-G → FAS (>>) |
| HLA-G → GLI3 (>>) |
| HLA-G → GNB5 (>>) |
| HLA-G → GRK6 (>>) |
| HLA-G → GRN (>>) |
| HLA-G → HLA-F (>>) |
| HLA-G → ICAM1 (>>) |
| HLA-G → IFITM3 (>>) |
| HLA-G → ITGB7 (>>) |
| HLA-G → MSN (>>) |
| HLA-G → MYO10 (>>) |
| HLA-G → NEUROG3 (>>) |
| HLA-G → NFKB2 (>>) |
| HLA-G → PDK2 (>>) |
| HLA-G → PPP1R11 (>>) |
| HLA-G → PPP3CB (>>) |
| HLA-G → PTAFR (>>) |
| HLA-G → RAD51L3 (>>) |
| HLA-G → RNF5 (>>) |
| HLA-G → SH2D2A (>>) |
| HLA-G → SOCS6 (>>) |
| HLA-G → SPATA2L (>>) |
| HLA-G → STAT1 (>>) |
| HLA-G → SUMF1 (>>) |
| HLA-G → TGFB2 (>>) |
| HLA-G → TXNIP (>>) |
| HLA-G → UBE2L6 (>>) |
| HLA-G → YWHAQ (>>) |
